Cargando…
m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
Background: The incidence of skin cutaneous melanoma (SKCM) has risen more rapidly than any other solid tumor in the past few decades. The median survival for metastatic melanoma is only six to nine months and the 5°years survival rate of patients with conventional therapy is less than 5%. Our aim w...
Autores principales: | Huang, Suyang, Lyu, Shanshan, Gao, Zhe, Zha, Weifeng, Wang, Ping, Shan, Yunyun, He, Jianzhong, Li, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131514/ https://www.ncbi.nlm.nih.gov/pubmed/34026852 http://dx.doi.org/10.3389/fmolb.2021.687760 |
Ejemplares similares
-
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023) -
Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
por: Li, Yang, et al.
Publicado: (2021) -
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021) -
Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022) -
A Pan-Cancer Landscape of HOX-Related lncRNAs and Their Association With Prognosis and Tumor Microenvironment
por: Shao, Wei, et al.
Publicado: (2021)